Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Cellect Biotechnology stock | $16.29

Learn how to easily invest in Cellect Biotechnology stock.

Cellect Biotechnology Ltd
- $0.48 ( - 2.95%)

Cellect Biotechnology Ltd is a biotechnology business based in the US. Cellect Biotechnology shares (APOP) are listed on the NASDAQ and all prices are listed in US Dollars. Cellect Biotechnology employs 12 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in Cellect Biotechnology

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – APOP – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Cellect Biotechnology stock price (NASDAQ: APOP)

Use our graph to track the performance of APOP stocks over time.

Cellect Biotechnology shares at a glance

Information last updated 2021-10-10.
Latest market close$16.29
52-week range$6.60 - $35.52
50-day moving average $21.04
200-day moving average $15.29
Wall St. target price$12.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.85

Buy Cellect Biotechnology shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
$20 per year
Financial advice powered by relationships, not commissions.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Cellect Biotechnology stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Cellect Biotechnology price performance over time

Historical closes compared with the close of $16.29 from 2021-10-14

1 week (2021-10-08) -7.13%
1 month (2021-09-15) 164.02%
3 months (2021-07-15) 295.39%
6 months (2021-04-15) 546.43%
1 year (2020-10-15) 633.78%
2 years (2019-10-15) 3,618.33%
3 years (2018-10-15) 219.41%
5 years (2016-10-14) 286.02%

Cellect Biotechnology financials

Gross profit TTM $0
Return on assets TTM -47.79%
Return on equity TTM -120.42%
Profit margin 0%
Book value $0.69
Market capitalisation $17.2 million

TTM: trailing 12 months

Shorting Cellect Biotechnology shares

There are currently 288,114 Cellect Biotechnology shares held short by investors – that's known as Cellect Biotechnology's "short interest". This figure is 88.7% up from 152,705 last month.

There are a few different ways that this level of interest in shorting Cellect Biotechnology shares can be evaluated.

Cellect Biotechnology's "short interest ratio" (SIR)

Cellect Biotechnology's "short interest ratio" (SIR) is the quantity of Cellect Biotechnology shares currently shorted divided by the average quantity of Cellect Biotechnology shares traded daily (recently around 4.8 million). Cellect Biotechnology's SIR currently stands at 0.06. In other words for every 100,000 Cellect Biotechnology shares traded daily on the market, roughly 60 shares are currently held short.

However Cellect Biotechnology's short interest can also be evaluated against the total number of Cellect Biotechnology shares, or, against the total number of tradable Cellect Biotechnology shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Cellect Biotechnology's short interest could be expressed as 0.07% of the outstanding shares (for every 100,000 Cellect Biotechnology shares in existence, roughly 70 shares are currently held short) or 0.0764% of the tradable shares (for every 100,000 tradable Cellect Biotechnology shares, roughly 76 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Cellect Biotechnology.

Find out more about how you can short Cellect Biotechnology stock.

Cellect Biotechnology share dividends

We're not expecting Cellect Biotechnology to pay a dividend over the next 12 months.

Have Cellect Biotechnology's shares ever split?

Cellect Biotechnology's shares were split on a 1:5 basis on 22 October 2019. So if you had owned 5 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Cellect Biotechnology shares – just the quantity. However, indirectly, the new 400% higher share price could have impacted the market appetite for Cellect Biotechnology shares which in turn could have impacted Cellect Biotechnology's share price.

Cellect Biotechnology share price volatility

Over the last 12 months, Cellect Biotechnology's shares have ranged in value from as little as $6.598 up to $35.52. A popular way to gauge a stock's volatility is its "beta".

APOP.US volatility(beta: 1.88)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cellect Biotechnology's is 1.8767. This would suggest that Cellect Biotechnology's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Cellect Biotechnology overview

Cellect Biotechnology Ltd. , a biotechnology company, engages in developing ApoGraft, a technology platform that functionally selects stem cells to enhance the safety of regenerative medicine and stem cell therapies in Israel. The company develops ApoTainer, a kit for hematopoietic stem cell transplantation procedures. It has collaborations with the denovoMATRIX group of the Technische Universität Dresden to conduct examinations into the tentative synergy between ApoGraft and denovoMAtrix technology for the purpose of evaluating collaborative development of products for regenerative medicine; Cell2in Inc. to conduct scientific evaluations combining ApoGraft with Cell2in's identification technology FreSHtracer, which monitors stem cell quality by utilizing a fluorescent dye to characterize their oxidative stress state; and XNK therapeutics to focus on the development of cell-based therapeutics from NK cells. The company was formerly known as Cellect Biomed Ltd. and changed its name to Cellect Biotechnology Ltd.

Frequently asked questions

What percentage of Cellect Biotechnology is owned by insiders or institutions?
Currently 3.647% of Cellect Biotechnology shares are held by insiders and 12.227% by institutions.
How many people work for Cellect Biotechnology?
Latest data suggests 12 work at Cellect Biotechnology.
When does the fiscal year end for Cellect Biotechnology?
Cellect Biotechnology's fiscal year ends in December.
Where is Cellect Biotechnology based?
Cellect Biotechnology's address is: 23 Hata?as Street, Kfar Saba, Israel, 44425
What is Cellect Biotechnology's ISIN number?
Cellect Biotechnology's international securities identification number is: US15116C2017
What is Cellect Biotechnology's CUSIP number?
Cellect Biotechnology's Committee on Uniform Securities Identification Procedures number is: 000241018

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site